(Q46738245)

English

Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia

scientific article published on 19 February 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18294294

Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18294294

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

extranodal NK/T-cell lymphoma, nasal type

1 reference

based on heuristic

inferred from title

author name string

Motoko Yamaguchi

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18294294

Ritsuro Suzuki

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18294294

Yok-Lam Kwong

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18294294

Won Seog Kim

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18294294

Yuichi Hasegawa

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18294294

Koji Izutsu

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18294294

Junji Suzumiya

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18294294

Takayuki Okamura

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18294294

Shigeo Nakamura

9

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18294294

Keisei Kawa

10

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18294294

Kazuo Oshimi

11

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18294294

publication date

19 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18294294

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18294294

99

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18294294

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18294294

1016-1020

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18294294

Progress in understanding and managing natural killer-cell malignancies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00768.X

21 January 2018

Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00768.X

21 January 2018

Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00768.X

21 January 2018

NK-cell neoplasms in Japan.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00768.X

21 January 2018

Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00768.X

21 January 2018

Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00768.X

21 January 2018

Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic viewpoints.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00768.X

21 January 2018

Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00768.X

21 January 2018

In vitro induction of apoptosis for nasal angiocentric natural killer cell lymphoma-derived cell line, NK-YS, by etoposide and cyclosporine A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00768.X

21 January 2018

First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00768.X

21 January 2018

Selective apoptosis of natural killer-cell tumours by l-asparaginase.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00768.X

21 January 2018

Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00768.X

21 January 2018

Nasal NK/T-cell lymphoma with disseminated disease treated with aggressive combined therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00768.X

21 January 2018

Effects of 4-hydroperoxy ifosfamide in combination with other anticancer agents on human cancer cell lines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00768.X

21 January 2018

Increase in topoisomerase-II-mediated DNA breaks and cytotoxicity of VP16 in human U937 lymphoma cells pretreated with low doses of methotrexate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00768.X

21 January 2018

Natural killer-cell malignancies: diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00768.X

21 January 2018

Revised response criteria for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00768.X

21 January 2018

Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00768.X

21 January 2018

Identifiers

10.1111/J.1349-7006.2008.00768.X

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18294294

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18294294

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46738245&oldid=2129120054"